{
  "ticker": "ABUS",
  "company_name": "Arbutus Biopharma Corporation",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT00927459",
      "title": "Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Hypercholesterolemia",
      "start_date": "2009-06",
      "completion_date": "2010-01",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    },
    {
      "nct_id": "NCT04775797",
      "title": "Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Chronic Hepatitis",
      "start_date": "2021-06-25",
      "completion_date": "2022-11-17",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    },
    {
      "nct_id": "NCT01262235",
      "title": "A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Cancer, Neuroendocrine Tumors, NET, Adrenocortical Carcinoma, ACC",
      "start_date": "2010-12",
      "completion_date": "2015-08",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    },
    {
      "nct_id": "NCT02041715",
      "title": "Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Ebola Virus Infection",
      "start_date": "2014-01",
      "completion_date": "2015-07",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    },
    {
      "nct_id": "NCT02631096",
      "title": "Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hepatitis B, Chronic",
      "start_date": "2015-12",
      "completion_date": "2018-05-18",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    },
    {
      "nct_id": "NCT04980482",
      "title": "Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Chronic Hepatitis b",
      "start_date": "2021-10-29",
      "completion_date": "2025-05-21",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    },
    {
      "nct_id": "NCT06277037",
      "title": "Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Long Term Follow-up",
      "start_date": "2024-07-11",
      "completion_date": "2029-10-30",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    },
    {
      "nct_id": "NCT01518881",
      "title": "Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Ebola Virus Infection",
      "start_date": "2012-01",
      "completion_date": "2012-07",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    },
    {
      "nct_id": "NCT05960240",
      "title": "Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Chronic Hepatitis b",
      "start_date": "2023-08-30",
      "completion_date": "2026-04",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    },
    {
      "nct_id": "NCT02191878",
      "title": "Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult, Liver Cell Carcinoma, Adult",
      "start_date": "2014-06",
      "completion_date": "2016-07",
      "enrollment": 0,
      "sponsor": "Arbutus Biopharma Corporation"
    }
  ],
  "summary": {
    "total_trials": 13,
    "by_phase": {
      "PHASE1": 5,
      "PHASE1, PHASE2": 2,
      "PHASE2": 5,
      "": 1
    },
    "by_status": {
      "TERMINATED": 5,
      "COMPLETED": 4,
      "RECRUITING": 2,
      "ACTIVE_NOT_RECRUITING": 1,
      "WITHDRAWN": 1
    },
    "active_trials": 3,
    "completed_trials": 4,
    "conditions": [
      "Cancer, Neuroendocrine Tumors, NET, Adrenocortical Carcinoma, ACC",
      "Chronic Hepatitis",
      "Chronic Hepatitis B",
      "Chronic Hepatitis b",
      "Ebola Virus Infection",
      "Hepatitis B, Chronic",
      "Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult, Liver Cell Carcinoma, Adult",
      "Hypercholesterolemia",
      "Long Term Follow-up"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:15:53.126276",
    "search_query": "Arbutus Biopharma Corporation",
    "url": "https://clinicaltrials.gov/search?term=Arbutus+Biopharma+Corporation"
  }
}